EI
ITCI

EAM Investors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

EAM Investors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-67,143
Closed -$4.81M – 344
2023
Q4 		$4.81M Buy
+67,143
New +$3.86M 0.85% 10
2023
Q3 		– Sell
-29,789
Closed -$1.89M – 397
2023
Q2 		$1.89M Buy
+29,789
New +$1.86M 0.35% 114
2022
Q3 		– Sell
-32,849
Closed -$1.88M – 360
2022
Q2 		$1.88M Sell
32,849
-7,481
-19% -$424K 0.46% 78
2022
Q1 		$2.47M Sell
40,330
-2,074
-5% -$108K 0.46% 72
2021
Q4 		$2.22M Buy
+42,404
New +$1.78M 0.36% 95
2021
Q3 		– Sell
-48,220
Closed -$1.97M – 408
2021
Q2 		$1.97M Buy
+48,220
New +$1.78M 0.3% 138
2020
Q4 		– Sell
-38,600
Closed -$990K – 399
2020
Q3 		$990K Buy
+38,600
New +$881K 0.23% 207
2016
Q3 		– Sell
-20,737
Closed -$805K – 372
2016
Q2 		$805K Sell
20,737
-9,861
-32% -$354K 0.12% 279
2016
Q1 		$851K Sell
30,598
-75,645
-71% -$2.52M 0.13% 270
2015
Q4 		$5.71M Buy
106,243
+11,075
+12% +$559K 0.75% 6
2015
Q3 		$3.81M Sell
95,168
-57,221
-38% -$1.87M 0.6% 23
2015
Q2 		$4.87M Buy
152,389
+106,257
+230% +$2.69M 0.57% 30
2015
Q1 		$1.1M Buy
+46,132
New +$1.03M 0.13% 295

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EAM Investors's ITCI Position: Q1 2024 in Review

EAM Investors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2024, closing a stake of 67,143 shares — an estimated $4.81M sold.

EAM Investors first reported a position in ITCI in Q1 2015 and held it in 13 quarters. The position peaked at $5.71M in Q4 2015. 345 funds tracked by Wall St. Rank hold ITCI as of Q1 2024.

  • EAM Investors reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2024 after selling out during the quarter.
  • EAM Investors sold 67,143 Intra-Cellular Therapies Inc. shares in Q1 2024, an estimated $4.81M.
  • EAM Investors first reported a position in Intra-Cellular Therapies Inc. in Q1 2015 and held it in 13 quarters.
  • EAM Investors's Intra-Cellular Therapies Inc. position peaked at $5.71M in Q4 2015.
  • 345 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2024.

Based on EAM Investors's 13F filing for Q1 2024, filed 13 May 2024.